CITED2 is a druggable epigenetic switch coupling neuronal maturation to regenerative decline

Area of Science:

• Neuroscience
• Regenerative Medicine
• Epigenetics

Background:

• Neuronal maturation involves growth cessation and polarity acquisition, leading to synapse formation.
• Maturation is essential for circuit stability but results in lost regenerative capacity after central nervous system (CNS) injury.
• Molecular mechanisms linking maturation to regenerative decline are not fully understood.

Purpose of the Study:

• To investigate the molecular programs that couple neuronal maturation to regenerative decline.
• To identify key regulators of sensory neuron plasticity and regenerative capacity after CNS injury.
• To explore therapeutic strategies for enhancing CNS repair.

Main Methods:

• Analysis of transcriptional and epigenetic signatures during dorsal root ganglion (DRG) neuron maturation.
• Investigating the role of the transcriptional co-regulator CITED2 in DRG neuron regeneration.
• In vivo studies of Cited2 overexpression and pharmacogenomic screening with Panobinostat after spinal cord injury (SCI).

Main Results:

• Transcriptional and epigenetic signatures for axon growth are lost during DRG neuron maturation.
• CITED2 is active in immature/regenerating neurons but silent after SCI; its overexpression enhances regeneration.
• CITED2 reinstates developmental profiles, decoupling maturation from regenerative failure.
• Panobinostat targets CITED2, promoting axonal growth, sprouting, and functional recovery post-SCI.

Conclusions:

• CITED2 acts as a key epigenetic switch, regulating sensory neuron plasticity and regenerative decline.
• CITED2 overexpression or Panobinostat treatment can enhance axonal regeneration and functional recovery after CNS injury.
• CITED2 represents a novel therapeutic target for promoting central nervous system repair.